Literature DB >> 15190192

The genetics and pathophysiology of diabetes mellitus type II.

A B Jenkins1, L V Campbell.   

Abstract

Type II diabetes is a common, complex and heterogeneous group of disorders of growing public health concern. Paradoxically, rare monogenic forms of diabetes mellitus have been the most informative regarding diabetes pathophysiology to date. We discuss disappointing results of genetic approaches thus far, emphasizing the genetic heterogeneity underlying the common phenotypic endpoint of elevated blood glucose level and the phenotypic misclassification in large studies resulting from this admixture and from the obligatory use of epidemiological or clinical surrogate measures. We suggest that novel approaches that take explicit account of the phenotypic, environmental and genetic complexities of type II diabetes are needed and discuss some principles that might underlie such approaches.

Entities:  

Mesh:

Year:  2004        PMID: 15190192     DOI: 10.1023/B:BOLI.0000031097.31587.81

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  47 in total

Review 1.  How many diseases does it take to map a gene with SNPs?

Authors:  K M Weiss; J D Terwilliger
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

Review 2.  Genetic associations in large versus small studies: an empirical assessment.

Authors:  John P A Ioannidis; Thomas A Trikalinos; Evangelia E Ntzani; Despina G Contopoulos-Ioannidis
Journal:  Lancet       Date:  2003-02-15       Impact factor: 79.321

Review 3.  Problems of reporting genetic associations with complex outcomes.

Authors:  Helen M Colhoun; Paul M McKeigue; George Davey Smith
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

Review 4.  Diabetes: mellitus or lipidus?

Authors:  E Shafrir; I Raz
Journal:  Diabetologia       Date:  2003-03-14       Impact factor: 10.122

5.  Evidence for gene-nutrient interaction at the PPARgamma locus.

Authors:  J Luan; P O Browne; A H Harding; D J Halsall; S O'Rahilly; V K Chatterjee; N J Wareham
Journal:  Diabetes       Date:  2001-03       Impact factor: 9.461

6.  Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.

Authors:  I Barroso; M Gurnell; V E Crowley; M Agostini; J W Schwabe; M A Soos; G L Maslen; T D Williams; H Lewis; A J Schafer; V K Chatterjee; S O'Rahilly
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

Review 7.  Mapping genes in diabetes. Genetic epidemiological perspective.

Authors:  S S Rich
Journal:  Diabetes       Date:  1990-11       Impact factor: 9.461

Review 8.  Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity.

Authors:  A T Hattersley
Journal:  Diabet Med       Date:  1998-01       Impact factor: 4.359

9.  Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians.

Authors:  Søren K Rasmussen; Søren A Urhammer; Lars Berglund; Jan N Jensen; Lars Hansen; Søren M Echwald; Knut Borch-Johnsen; Yukio Horikawa; Hirosato Mashima; Hans Lithell; Nancy J Cox; Torben Hansen; Graeme I Bell; Oluf Pedersen
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

10.  Multiple indexes of lipid availability are independently related to whole body insulin action in healthy humans.

Authors:  Adamandia D Kriketos; Stuart M Furler; Seng Khee Gan; Ann M Poynten; Donald J Chisholm; Lesley V Campbell
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

View more
  1 in total

1.  Segregation of a latent high adiposity phenotype in families with a history of type 2 diabetes mellitus implicates rare obesity-susceptibility genetic variants with large effects in diabetes-related obesity.

Authors:  Arthur B Jenkins; Marijka Batterham; Dorit Samocha-Bonet; Katherine Tonks; Jerry R Greenfield; Lesley V Campbell
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.